AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Telmisartan; Amlodipine in Nigeria
6 products registered with NAFDAC — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Embateltan A40 Plus Tablet_ Tablet | A4-101587 | Embassy Pharmaceutical and Chemicals Limited | active | 28 Oct 2030 |
| Embateltan A80 Plus Tablet_ Tablet | A4-101588 | Embassy Pharmaceutical and Chemicals Limited | active | 28 Oct 2030 |
| Cilzec-A 40+5 Tablets_ Tablet | A4-101536 | Mega Lifesciences Nigeria Limited | active | 23 Sept 2030 |
| Cilzec-A 40+10 Tablets_ Tablet | A4-101535 | Mega Lifesciences Nigeria Limited | active | 23 Sept 2030 |
| Cilzec-A 80+10 Tablets_ Tablet | A4-101533 | Mega Lifesciences Nigeria Limited | active | 23 Sept 2030 |
| Cilzec-A 80+5 Tablets_ Tablet | A4-101534 | Mega Lifesciences Nigeria Limited | active | 23 Sept 2030 |
Telmisartan; Amlodipine — NAFDAC Registration Details
NAFDAC (Nigeria) has 6 registered products containing Telmisartan; Amlodipine, of which 6 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Telmisartan; Amlodipine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.